WELL HEALTH TECH CORP ORD - WHTCF STOCK NEWS

WELL Health Technologies Corp. announces significant growth milestones for its subsidiary, OceanMD, with over 4,700 clinics and hospitals and 37,000 active users in Canada. The company saw 78% YoY growth in total sites and 65% YoY growth in active users. Ocean Platform sends over 1.2 million referrals annually, reflecting a 50% YoY increase. The upcoming launch of Health Messenger in Q2-2024 aims to improve healthcare provider-patient communications.

WELL Health Technologies Corp. announces integration update to streamline operations and drive profitable growth. The company restructures its business into three key components overseen by key leaders to enhance synergies and innovation. The PR highlights revenue forecasts, cost optimization programs, and strategic initiatives for growth.

WELL Health Technologies Corp. has announced the creation of a dedicated public sector group to provide support to large scale health systems and care delivery networks in Canada. The company aims to combine and deliver product offerings specifically suited for the public sector's unique scale and requirements, leveraging its operating strengths, including Canada's leading provider-centric technology platform and the largest network of outpatient clinics in the country. WELL has appointed Shane Sabatino as head of public sector partnerships to oversee this division.

WELL Health Technologies Corp. (WELL) has successfully closed the refinancing of a new credit facility for its subsidiary, WELL Health USA. The facility, led by JPMorgan Chase Bank, N.A., includes a primary $175M credit facility with an additional $125M accordion for future growth. The refinanced credit facility matures in three years and carries a floating interest rate. The arrangement enhances WELL USA's financial flexibility, essential for executing its strategic growth plans and maintaining its commitment to financial discipline. The syndicate includes JPMorgan Chase Bank, N.A., CIBC, HSBC Canada, The Bank of Nova Scotia, The Bank of Montreal, and The Export Development Corporation. The CEO, Hamed Shahbazi, expressed gratitude for the support and leadership of the syndicate members.

WELL Health Technologies Corp. expects to announce record quarterly revenue and positive EPS for Q4-2023. The company achieved its 20th consecutive quarter of record quarterly revenue, driven by double-digit YoY organic growth and inorganic growth in both US and Canadian patient visits. The BC clinics achieved a record Net Promoter Score of 80% in Q4-2023 compared to the industry average of 34% for the Canadian healthcare sector. WELL's patient visits and Total Care Interactions metrics are expected to report record revenue for Q4-2023.

WELL Health Technologies Corp. (WELL) has announced substantial growth through its clinic recruitment, absorption, and acquisition program, adding two Canadian clinics generating $28 million in annualized revenues for less than $400,000 in Q4-2023. The company operates 167 clinics in 98 facilities across Canada and has initiated an enterprise-wide cost optimization initiative to improve cost efficiency and operating cash flow. Additionally, its subsidiary, OceanMD, has started a collaboration with the Provincial Health Services Authority in British Columbia, signaling significant growth opportunities in the public sector.

WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) has been certified as a Great Place to Work® by Great Place to Work Institute® Canada, and three of its portfolio companies, Insig, Adracare, and OceanMD, have achieved ISO 27001 certification, reinforcing WELL's commitment to workplace culture, trust, inclusivity, and data protection in telehealth and digital patient engagement.

WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) partners with Vancouver Canucks to provide advanced healthcare services, including WELL Longevity+ program for athletes and premium seat holders, as well as the launch of the WELL Health President's Club.

WELL Health Technologies Corp. (TSX: WELL) announces strategic investments in Pillway, ORX AI, and doctorly GmbH, with Sun Life investing $9.5 million in Pillway, WELL Ventures completing a new investment in ORX AI, and doctorly securing a new round of funding of €6.7M in Series A Extension. These investments reinforce WELL's leadership in fostering innovation within the digital health technology sphere.